CDC committee supports expanded criteria for PCV13 vaccine

02/27/2013 | AAFP News Now

The CDC's Advisory Committee on Immunization Practices voted to expand age recommendations for certain individuals for the 13-valent pneumococcal conjugate vaccine and to include the Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid vaccine for high-risk children in the Vaccines for Children program. The committee approved four new influenza vaccine formulations for the 2013-14 flu season, along with recommendations for timing and spacing of vaccinations.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park